

Lip gloss, gum, and the Pill
12 snips Mar 14, 2024
Lux Alptraum, a freelance journalist focused on sex health, joins Megan Kavanaugh, a principal researcher at the Guttmacher Institute, to discuss the recent approval of over-the-counter birth control pills. They dive into the implications of this historic decision, revealing that availability doesn't equate to accessibility. The duo tackles the challenges low-income women face post-Dobbs and highlights the urgent need for reliable information and a comprehensive approach to reproductive health care. Their insights illuminate the complex landscape of contraception options and access.
AI Snips
Chapters
Transcript
Episode notes
US Delay in OTC Birth Control
- Over 100 countries offer over-the-counter birth control pills safely.
- The U.S. delay stems from a distrust of individuals managing their reproductive health.
Plan B as Precursor
- Plan B's over-the-counter approval paved the way for O-Pill's acceptance.
- The urgent need for emergency contraception made the argument for accessibility stronger.
Ideal Contraceptive Access
- Ideal contraceptive access allows individuals to choose methods fitting their needs.
- Access should be easy regardless of location or life stage.